Xiaotong Hou
Clinical trials sponsored by Xiaotong Hou, explained in plain language.
-
New blood thinner could make Heart-Lung machines safer after surgery
Disease control Recruiting nowThis study compares a drug called nafamostat mesilate to the standard blood thinner heparin in 80 adults who need a heart-lung machine (ECMO) after heart surgery. The goal is to see if nafamostat prevents dangerous blood clots as well as heparin, but with fewer bleeding complicat…
Phase: NA • Sponsor: Xiaotong Hou • Aim: Disease control
Last updated May 26, 2026 11:14 UTC
-
Blood thinner showdown: could bivalirudin be safer for ECMO patients?
Disease control Recruiting nowThis study tests whether bivalirudin, a blood thinner, works better and causes fewer side effects than the standard drug heparin for patients on ECMO (a machine that helps the heart and lungs). About 154 adults on ECMO will be randomly assigned to receive either drug. The goal is…
Phase: NA • Sponsor: Xiaotong Hou • Aim: Disease control
Last updated May 26, 2026 11:11 UTC